Table 1 Mortality data for the RECOVERY trial stratified by patient group
From: Should RECOVERY have used response adaptive randomisation? Evidence from a simulation study
Patient subgroup | Number allocated standard care | Number allocated dexamethasone | Number allocated hydroxy-chloroquine | Number allocated lopinavir | Mortality on standard care | Mortality on dexamethasone | Mortality on hydroxy-chloroquine | Mortality on lopinavir |
|---|---|---|---|---|---|---|---|---|
No oxygen | 1034 | 501 | 362 | 425 | 14.0% | 17.8% | 16.0% | 16.7% |
Oxygen-only | 2604 | 1279 | 938 | 1131 | 26.2% | 23.3% | 27.0% | 24.7% |
Invasive ventilation | 683 | 324 | 261 | 60 | 41.4% | 29.3% | 42.1% | 40.0% |